BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7602795)

  • 1. [Diagnosis of hematological disorders by mutational analysis of oncogenes].
    Hirai H
    Rinsho Byori; 1995 Jun; 43(6):529-34. PubMed ID: 7602795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AML1/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity on Rat1 fibroblasts with dependence on the Evi-1 sequence.
    Kurokawa M; Ogawa S; Tanaka T; Mitani K; Yazaki Y; Witte ON; Hirai H
    Oncogene; 1995 Sep; 11(5):833-40. PubMed ID: 7675444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia.
    Mitani K; Ogawa S; Tanaka T; Miyoshi H; Kurokawa M; Mano H; Yazaki Y; Ohki M; Hirai H
    EMBO J; 1994 Feb; 13(3):504-10. PubMed ID: 8313895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of blastic crisis in chronic myelocytic leukemia.
    Mitani K
    Leukemia; 1997 Apr; 11 Suppl 3():503-5. PubMed ID: 9209439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.
    Linggi B; Müller-Tidow C; van de Locht L; Hu M; Nip J; Serve H; Berdel WE; van der Reijden B; Quelle DE; Rowley JD; Cleveland J; Jansen JH; Pandolfi PP; Hiebert SW
    Nat Med; 2002 Jul; 8(7):743-50. PubMed ID: 12091906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel gene, FGA7, is fused to RUNX1/AML1 in a t(4;21)(q28;q22) in a patient with T-cell acute lymphoblastic leukemia.
    Mikhail FM; Coignet L; Hatem N; Mourad ZI; Farawela HM; El Kaffash DM; Farahat N; Nucifora G
    Genes Chromosomes Cancer; 2004 Feb; 39(2):110-8. PubMed ID: 14695990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal approaches to hematopoietic oncogenesis.
    Nowell PC
    Stem Cells; 1993 Jan; 11(1):9-19. PubMed ID: 8457784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent chromosomal translocations and fusion genes in leukemia-lymphoma cell lines.
    Drexler HG; MacLeod RA; Borkhardt A; Janssen JW
    Leukemia; 1995 Mar; 9(3):480-500. PubMed ID: 7885046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias.
    Tanaka T; Mitani K; Kurokawa M; Ogawa S; Tanaka K; Nishida J; Yazaki Y; Shibata Y; Hirai H
    Mol Cell Biol; 1995 May; 15(5):2383-92. PubMed ID: 7739522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO.
    Fliegauf M; Stock M; Berg T; Lübbert M
    Oncogene; 2004 Dec; 23(56):9070-81. PubMed ID: 15489901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of t(3 ; 21) (q26 ; q22) with AML1/EVI1 mRNA during progression of myelodysplastic syndrome to acute myeloid leukemia].
    Choi I; Goto T; Nagano M; Muta K; Yufu Y; Uike N; Kozuru M; Abe Y; Nisimura J
    Rinsho Ketsueki; 1999 Jun; 40(6):518-20. PubMed ID: 10422292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core-binding factor: a central player in hematopoiesis and leukemia.
    Speck NA; Stacy T; Wang Q; North T; Gu TL; Miller J; Binder M; Marín-Padilla M
    Cancer Res; 1999 Apr; 59(7 Suppl):1789s-1793s. PubMed ID: 10197598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oncogenes and leukemia: history and perspectives].
    Gisselbrecht S
    Med Sci (Paris); 2003 Feb; 19(2):201-10. PubMed ID: 12836614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22).
    Zhang Y; Emmanuel N; Kamboj G; Chen J; Shurafa M; Van Dyke DL; Wiktor A; Rowley JD
    Genes Chromosomes Cancer; 2004 Aug; 40(4):365-70. PubMed ID: 15188461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the novel AML1 fusion partner gene, LAF4, a fusion partner of MLL, in childhood T-cell acute lymphoblastic leukemia with t(2;21)(q11;q22) by bubble PCR method for cDNA.
    Chinen Y; Taki T; Nishida K; Shimizu D; Okuda T; Yoshida N; Kobayashi C; Koike K; Tsuchida M; Hayashi Y; Taniwaki M
    Oncogene; 2008 Apr; 27(15):2249-56. PubMed ID: 17968322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal expression of Evi-1 gene in human leukemias.
    Ogawa S; Mitani K; Kurokawa M; Matsuo Y; Minowada J; Inazawa J; Kamada N; Tsubota T; Yazaki Y; Hirai H
    Hum Cell; 1996 Dec; 9(4):323-32. PubMed ID: 9183665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics of human leukemias: new insights into therapy.
    Gilliland DG
    Semin Hematol; 2002 Oct; 39(4 Suppl 3):6-11. PubMed ID: 12447846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of single colonies reveals a diverse origin of initial clonal proliferation in B-precursor acute lymphoblastic leukemia that can precede the t(12;21) translocation.
    Weston VJ; McConville CM; Mann JR; Darbyshire PJ; Lawson S; Gordon J; Moss PA; Taylor AM; Stankovic T
    Cancer Res; 2001 Dec; 61(23):8547-53. PubMed ID: 11731441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatin structural elements and chromosomal translocations in leukemia.
    Zhang Y; Rowley JD
    DNA Repair (Amst); 2006 Sep; 5(9-10):1282-97. PubMed ID: 16893685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.